AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20555312 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (all doses)
Number of subjects: 514
Study 20555312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 514
Study 18690985 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone-Vancomycin fixed-dose combination 1.5 g B.D. for 3-10 days (Group A, n=106)
Number of subjects: 305
Study 18690985 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone-Vancomycin fixed-dose combination 3.0 g B.D. for 3-10 days (Group B, n=199)
Number of subjects: 305
Study 18690985 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone-Vancomycin fixed-dose combination
Number of subjects: 305
Study 15853114 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide
Number of subjects: 24
Study 15853114 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% carbamide peroxide with fluoride
Number of subjects: 24
Study 15853114 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide
Number of subjects: 24
Study 15853114 — intervention group
Group type: COMPARATOR
Intervention: Control specimens
Number of subjects: 24
Study 12379544 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin 2 x 400 mg for 4 days and topical gentamicin and polymyxin
Number of subjects: 546
Study 12379544 — intervention group
Group type: COMPARATOR
Intervention: Intravenous and topical placebo
Number of subjects: 546
Study 12379544 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin and topical antibiotics
Number of subjects: 546
Study 9844953 — intervention group
Group type: EXPERIMENTAL
Intervention: Bech-Rafaelsen Melancholia Scale (BRMES)
Number of subjects: 132
Study 8092089 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g raw potato starch (54% RS)
Number of subjects: 10
Study 8092089 — intervention group
Group type: COMPARATOR
Intervention: 50 g pregelatinized starch (0% RS)
Number of subjects: 10
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Kenalog creams 0.025%
Number of subjects: 0
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Aristocort creams 0.025%
Number of subjects: 0
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Aristocort ointments 0.1%
Number of subjects: 0
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Aristocort creams 0.5%
Number of subjects: 0
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Hytone cream 1.0%
Number of subjects: 0
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Synalar creams 0.01%
Number of subjects: 0
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Topicort creams 0.25%
Number of subjects: 0
Study 2817915 — intervention group
Group type: EXPERIMENTAL
Intervention: Vallisone creams 0.1%
Number of subjects: 0
Study 1215862 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of orciprenaline aerosol
Number of subjects: 12
Study 1215862 — intervention group
Group type: COMPARATOR
Intervention: Spraying the oropharynx with orciprenaline aerosol
Number of subjects: 12
Study 7406656 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemoline (Cylert)
Number of subjects: 60
Study 7406656 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (Ritalin) hydrochloride
Number of subjects: 60
Study 7406656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30832581 — intervention group
Group type: EXPERIMENTAL
Intervention: CarFreeMe intervention, an intensive program delivered by a trained health professional, covering seven modules addressing practical and emotional needs relevant to driving cessation.
Number of subjects: 0
Study 30832581 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (control group).
Number of subjects: 0
Study 28097926 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally supervised home exercise program (8 weeks)
Number of subjects: 30
Study 28097926 — intervention group
Group type: COMPARATOR
Intervention: Standard care group (n = 14)
Number of subjects: 30
Study 24259406 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 13
Study 24259406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 23350957 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cycling at 70% of maximum oxygen uptake for 20 minutes
Number of subjects: 9
Study 23350957 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint interval cycling (four 30-second bouts with 4.5 minutes recovery)
Number of subjects: 9
Study 23350957 — intervention group
Group type: COMPARATOR
Intervention: Control (rest)
Number of subjects: 9
Study 21561483 — intervention group
Group type: EXPERIMENTAL
Intervention: Straumann bone ceramic(®) (SBC) with a collagen barrier membrane (Bio‐Gide(®))
Number of subjects: 27
Study 21561483 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized bovine bone mineral with the same barrier
Number of subjects: 27
Study 21561483 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (SBC and deproteinized bovine bone)
Number of subjects: 27
Study 21561483 — intervention group
Group type: EXPERIMENTAL
Intervention: SBC
Number of subjects: 27
Study 19694333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus fluorouracil with pelvic radiotherapy
Number of subjects: 20
Study 19694333 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin with pelvic radiotherapy
Number of subjects: 20
Study 17725736 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmodified RBCs (UN‐RBCs, n = 18)
Number of subjects: 35
Study 17725736 — intervention group
Group type: COMPARATOR
Intervention: Leukoreduced RBCs (LR‐RBCs, n = 17)
Number of subjects: 35
Study 17725736 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmodified RBCs (UN‐RBCs)
Number of subjects: 35
Study 15496274 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth factor priming using filgrastim (G‐CSF) and sagramostim (GM‐CSF)
Number of subjects: 0
Study 15496274 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment regimens without growth factor priming
Number of subjects: 0
Study 12352780 — intervention group
Group type: EXPERIMENTAL
Intervention: Calming music
Number of subjects: 68
Study 12352780 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand massage
Number of subjects: 68
Study 12352780 — intervention group
Group type: EXPERIMENTAL
Intervention: Calming music and hand massage simultaneously
Number of subjects: 68
Study 12352780 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 68
Study 9836318 — intervention group
Group type: EXPERIMENTAL
Intervention: Task arrangement involving mobility
Number of subjects: 3
Study 9836318 — intervention group
Group type: COMPARATOR
Intervention: Task arrangement involving sedentariness
Number of subjects: 3
Study 8009691 — intervention group
Group type: EXPERIMENTAL
Intervention: Incision, curettage, and suture under antibiotic cover
Number of subjects: 0
Study 8009691 — intervention group
Group type: COMPARATOR
Intervention: Marsupialization
Number of subjects: 0
Study 2529814 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 59
Study 2529814 — intervention group
Group type: COMPARATOR
Intervention: Teicoplanin
Number of subjects: 59
Study 54336 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi antigen at dosages of 25, 50, and 100 mug
Number of subjects: 0
Study 54336 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi antigen
Number of subjects: 0
Study 54336 — intervention group
Group type: COMPARATOR
Intervention: Standard typhoid vaccine (lot 6A)
Number of subjects: 0
Study 30803000 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning approach using 3 T CEST data to predict 9.4 T CEST signals; low saturation power of B1 = 0.6 µT.
Number of subjects: 2
Study 30803000 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning approach applied to tumor patient data.
Number of subjects: 2
Study 29166184 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarter prone position
Number of subjects: 15
Study 29166184 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 15
Study 26400262 — intervention group
Group type: COMPARATOR
Intervention: Protein mix (3×20 g/d) for 4 weeks
Number of subjects: 100
Study 26400262 — intervention group
Group type: COMPARATOR
Intervention: Protein mix
Number of subjects: 100
Study 26400262 — intervention group
Group type: COMPARATOR
Intervention: Pea protein, milk protein, egg-white protein
Number of subjects: 100
Study 26400262 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin
Number of subjects: 100
Study 22864510 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloader knee orthosis
Number of subjects: 24
Study 22864510 — intervention group
Group type: EXPERIMENTAL
Intervention: Laterally wedged insoles (6° lateral wedge)
Number of subjects: 24
Study 21312265 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg/d for 52 weeks
Number of subjects: 2302
Study 19204233 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographic bioimaging analysis of stromal keratitis
Number of subjects: 169
Study 19204233 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical measurements of stromal keratitis
Number of subjects: 169
Study 19204233 — intervention group
Group type: EXPERIMENTAL
Intervention: Necrotizing stromal keratitis
Number of subjects: 169
Study 17406745 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression profile assessment for adjuvant therapy decision
Number of subjects: 8000
Study 17406745 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant therapy based on gene expression profile
Number of subjects: 8000
Study 14756386 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg capsule from Laboratório Teuto Brasileiro Ltd.
Number of subjects: 24
Study 14756386 — intervention group
Group type: COMPARATOR
Intervention: Zoltec 150 mg capsule from Laboratórios Pfizer Ltd.
Number of subjects: 24
Study 12463387 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 29
Study 12463387 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 29
Study 12463387 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 29
Study 9728946 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine (dopaminergic stimulation)
Number of subjects: 4
Study 9728946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 8081350 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES), 45 min daily, 4 days a week for 3 weeks
Number of subjects: 10
Study 8081350 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (placebo control)
Number of subjects: 10
Study 8081350 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 10
Study 2529105 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 10
Study 2529105 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide
Number of subjects: 10
Study 2529105 — intervention group
Group type: COMPARATOR
Intervention: Cromolyn sodium
Number of subjects: 10
Study 2529105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 782464 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone plus azathioprine
Number of subjects: 14
Study 782464 — intervention group
Group type: COMPARATOR
Intervention: Prednisone plus low-dose azathioprine and cyclophosphamide
Number of subjects: 14
Study 31859735 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative samples
Number of subjects: 714
Study 31859735 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative care
Number of subjects: 714
Study 31859735 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk samples
Number of subjects: 714
Study 28183580 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (propofol)
Number of subjects: 40
Study 28183580 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anesthesia (volatile anesthetics)
Number of subjects: 40
Study 26452162 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapler hepatectomy
Number of subjects: 40
Study 26452162 — intervention group
Group type: COMPARATOR
Intervention: CUSA resection
Number of subjects: 40
Study 23565895 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral training of both the seller and the buyer within a dyad
Number of subjects: 360
Study 23565895 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral training of the seller
Number of subjects: 360
Study 23565895 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral training of the buyer
Number of subjects: 360
Study 23565895 — intervention group
Group type: COMPARATOR
Intervention: No-training control condition
Number of subjects: 360
Study 22259246 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO)
Number of subjects: 22
Study 22259246 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 22
Study 18951818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150-600 mg/day
Number of subjects: 1174
Study 18951818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1174
Study 17230434 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative binomial model for treatment analysis
Number of subjects: 1465
Study 17230434 — intervention group
Group type: EXPERIMENTAL
Intervention: Poisson regression
Number of subjects: 1465
Study 17230434 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-parametric methods
Number of subjects: 1465
Study 15041086 — intervention group
Group type: EXPERIMENTAL
Intervention: Aware condition (objective monitoring)
Number of subjects: 0
Study 15041086 — intervention group
Group type: COMPARATOR
Intervention: Unaware condition (no objective monitoring)
Number of subjects: 0
Study 15041086 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliant samples
Number of subjects: 0
Study 15041086 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-compliant samples
Number of subjects: 0
Study 15041086 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 0
Study 15041086 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon sample (1600 h)
Number of subjects: 0
Study 15041086 — intervention group
Group type: EXPERIMENTAL
Intervention: Last 3 days of sampling
Number of subjects: 0
Study 15041086 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekdays vs weekends
Number of subjects: 0
Study 11331840 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacron-patch closure
Number of subjects: 274
Study 11331840 — intervention group
Group type: COMPARATOR
Intervention: Vein-patch closure
Number of subjects: 274
Study 9218080 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily
Number of subjects: 432
Study 9218080 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg b.d.
Number of subjects: 432
Study 8110919 — intervention group
Group type: EXPERIMENTAL
Intervention: Slight Deviants (3% frequency change) presented in unattended input stream
Number of subjects: 0
Study 8110919 — intervention group
Group type: EXPERIMENTAL
Intervention: Widely Deviants (5% frequency change) presented in unattended input stream
Number of subjects: 0
Study 8110919 — intervention group
Group type: COMPARATOR
Intervention: Reading condition with same stimuli
Number of subjects: 0
Study 3333521 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salt diet
Number of subjects: 0
Study 3333521 — intervention group
Group type: EXPERIMENTAL
Intervention: High salt diet
Number of subjects: 0
Study 29409064 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 61
Study 29409064 — intervention group
Group type: COMPARATOR
Intervention: Vardenafil (10 mg daily)
Number of subjects: 61
Study 29409064 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent CPAP
Number of subjects: 61
Study 29409064 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent Vardenafil
Number of subjects: 61
Study 26800181 — intervention group
Group type: EXPERIMENTAL
Intervention: Single centrifugation group (SCG)
Number of subjects: 15
Study 26800181 — intervention group
Group type: EXPERIMENTAL
Intervention: Double centrifugation group (DCG)
Number of subjects: 15
Study 26800181 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 15
Study 24334825 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 97
Study 22172981 — intervention group
Group type: EXPERIMENTAL
Intervention: Category-cued recall task under divided attention
Number of subjects: 0
Study 22172981 — intervention group
Group type: EXPERIMENTAL
Intervention: Category-exemplar generation task following category judgment task
Number of subjects: 0
Study 20589875 — intervention group
Group type: EXPERIMENTAL
Intervention: Eszopiclone
Number of subjects: 30
Study 20589875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17604046 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (change rate of >=2 ECG stages per 2 days)
Number of subjects: 27
Study 17604046 — intervention group
Group type: COMPARATOR
Intervention: Group B (no rapid change)
Number of subjects: 27
Study 17604046 — intervention group
Group type: COMPARATOR
Intervention: Reocclusion cases
Number of subjects: 27
Study 17162863 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (oral, two times a day) plus Tobradex and Diclofenac sodium eyedrops (four times a day)
Number of subjects: 0
Study 17162863 — intervention group
Group type: COMPARATOR
Intervention: Tobradex and Diclofenac sodium eyedrops (four times a day)
Number of subjects: 0
Study 11869406 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminder one day prior to appointment
Number of subjects: 171
Study 11869406 — intervention group
Group type: COMPARATOR
Intervention: Routine booking (no reminder)
Number of subjects: 171
Study 10195531 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025 mg intrathecal morphine
Number of subjects: 143
Study 10195531 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg intrathecal morphine
Number of subjects: 143
Study 10195531 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg intrathecal morphine
Number of subjects: 143
Study 10195531 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg intrathecal morphine
Number of subjects: 143
Study 10195531 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia (systemic morphine)
Number of subjects: 143
Study 7756098 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen, 400 mg three times daily for 3 days
Number of subjects: 12
Study 7756098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1518268 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02 microM methotrexate (MTX) and 2 microM 6-mercaptopurine (6MP) combination treatment
Number of subjects: 0
Study 1518268 — intervention group
Group type: COMPARATOR
Intervention: Intravenous MTX (5 g/m2)
Number of subjects: 0
Study 1518268 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous MTX followed by 6MP (1.3 g/m2)
Number of subjects: 0
Study 4053513 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vasopressin (1‐3 mu‐units min‐1 kg‐1)
Number of subjects: 0
Study 4053513 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (2.4 g)
Number of subjects: 0
Study 4053513 — intervention group
Group type: EXPERIMENTAL
Intervention: Termination of vasopressin infusion
Number of subjects: 0
Study 4053513 — intervention group
Group type: COMPARATOR
Intervention: Aspirin administration
Number of subjects: 0
Study 30271161 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 72
Study 30271161 — intervention group
Group type: COMPARATOR
Intervention: Pitavastatin with sarpogrelate (PS)
Number of subjects: 72
Study 27238052 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowable bulk-filled resin composite (SDR)
Number of subjects: 86
Study 27238052 — intervention group
Group type: COMPARATOR
Intervention: Resin composite-only (Ceram X mono+)
Number of subjects: 86
Study 26524515 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered Family Navigator services
Number of subjects: 0
Study 26524515 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 23083704 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigated total knee arthroplasty
Number of subjects: 200
Study 23083704 — intervention group
Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 200
Study 20810155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 63
Study 17932223 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-h modified release formulation of UK-338,003
Number of subjects: 0
Study 17932223 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-h modified release formulation of UK-338,003
Number of subjects: 0
Study 17932223 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic intubation of UK-338,003
Number of subjects: 0
Study 17932223 — intervention group
Group type: EXPERIMENTAL
Intervention: PGP inhibition in mouse intestine
Number of subjects: 0
Study 17932223 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex vivo human distal intestine
Number of subjects: 0
Study 16845959 — intervention group
Group type: EXPERIMENTAL
Intervention: Block anesthesia of nerve
Number of subjects: 80
Study 16845959 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraperiosteal infiltration
Number of subjects: 80
Study 16845959 — intervention group
Group type: COMPARATOR
Intervention: Periodontal membrane injection
Number of subjects: 80
Study 16845959 — intervention group
Group type: COMPARATOR
Intervention: Intrapulpal injection
Number of subjects: 80
Study 12786704 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% sodium tetradecyl sulfate (STS)
Number of subjects: 13
Study 12786704 — intervention group
Group type: COMPARATOR
Intervention: 72% glycerin
Number of subjects: 13
Study 10985709 — intervention group
Group type: EXPERIMENTAL
Intervention: Early shock (< 24 h)
Number of subjects: 815
Study 10985709 — intervention group
Group type: EXPERIMENTAL
Intervention: Late shock (≥ 24 h)
Number of subjects: 815
Study 10985709 — intervention group
Group type: COMPARATOR
Intervention: Early shock
Number of subjects: 815
Study 10985709 — intervention group
Group type: COMPARATOR
Intervention: Late shock
Number of subjects: 815
Study 7884505 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete 99mTc-labeled anti-CEA IgG1 BW 431/26
Number of subjects: 25